Valeriy Bondar

Recent publications · Crossref

5 total works indexed

1. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

   · 2020 · cited 6,449x

2. 2018 ESC/EACTS Guidelines on myocardial revascularization

   · 2018 · cited 5,459x

3. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

   · 2017 · cited 3,075x

4. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   · 2019 · cited 2,540x

5. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

   · 2017 · cited 2,366x

via Crossref · CC0